BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16125569)

  • 21. New approaches for the prevention of rejection and graft-vs.-host disease in clinical bone marrow transplantation.
    Slavin S; Or R; Naparstek E; Cividalli G; Weshler Z; Weiss L; Mumcuoglu M; Engelhard D; Aker M; Pollack A
    Isr J Med Sci; 1986; 22(3-4):264-7. PubMed ID: 3528046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of transplantation with partial T-cell depletion of matched or mismatched unrelated or partially matched related donor bone marrow in children and adolescents with leukemias.
    Bunin N; Aplenc R; Leahey A; Magira E; Grupp S; Pierson G; Monos D
    Bone Marrow Transplant; 2005 Jan; 35(2):151-8. PubMed ID: 15531896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
    Slavin S; Or R; Naparstek E; Weiss L; Mumcuoglu M; Weshler Z; Brautbar H; Cividalli G; Glikson M; Hale G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2614-5. PubMed ID: 3274569
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients.
    Ringdén O; Pihlstedt P; Markling L; Aschan J; Båryd I; Ljungman P; Lönnqvist B; Tollemar J; Janossy G; Sundberg B
    Bone Marrow Transplant; 1991 Mar; 7(3):221-6. PubMed ID: 2059758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-identical marrow transplantation in the leukemias without T-cell depletion. The Seattle Marrow Transplant Team.
    Storb R; Appelbaum F; Buckner CD; Clift R; Anasetti C; Beatty P; Bianco J; Doney K; Hansen J; Martin P
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():80-4. PubMed ID: 2117976
    [No Abstract]   [Full Text] [Related]  

  • 29. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
    Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma.
    Przepiorka D; Giralt S; Huh YO; Andreeff M; Luna M; Reading C; Thomas M; Champlin RE
    Transplant Proc; 1992 Dec; 24(6):2906-7. PubMed ID: 1465994
    [No Abstract]   [Full Text] [Related]  

  • 31. Haploidentical bone marrow transplantation in primary immune deficiency: stem cell selection and manipulation.
    Hagin D; Reisner Y
    Immunol Allergy Clin North Am; 2010 Feb; 30(1):45-62. PubMed ID: 20113886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets.
    Przepiorka D; Huh YO; Khouri I; Reading C; Hester J; Marshall M; Champlin RE
    Prog Clin Biol Res; 1994; 389():557-63. PubMed ID: 7700921
    [No Abstract]   [Full Text] [Related]  

  • 33. Critical issues in bone marrow transplantation.
    Storb R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2774-81. PubMed ID: 3547955
    [No Abstract]   [Full Text] [Related]  

  • 34. Proteasome inhibitor clioquinol as a candidate drug in prophylaxis and treatment of acute graft-versus-host disease.
    Liang Y; Mao X; Liu H
    Med Hypotheses; 2011 Mar; 76(3):400-2. PubMed ID: 21122999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-cell depletion in allogeneic bone marrow transplantation for acute leukaemias.
    Aversa F; Terenzi A; Carotti A; Velardi A; Latini P; Gambelunghe C; Grignani F; Martelli MF
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():69-72. PubMed ID: 2697440
    [No Abstract]   [Full Text] [Related]  

  • 36. Improved immune function with donor B-cell infusion after semi-allogeneic bone marrow transplantation in mice.
    Samuel S; Azar Y; Corchia N; Or R
    Arch Med Res; 2008 Jan; 39(1):61-8. PubMed ID: 18067997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed chimerism after allogeneic bone marrow transplantation for leukemias.
    Bertheas MF; Lafage M; Blaise D; Stoppa AM; Viens P; Mannoni P; Maraninchi D
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():61-3. PubMed ID: 2390641
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.
    Ash RC; Casper JT; Chitambar CR; Hansen R; Bunin N; Truitt RL; Lawton C; Murray K; Hunter J; Baxter-Lowe LA
    N Engl J Med; 1990 Feb; 322(8):485-94. PubMed ID: 2300120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cell depletion and allogeneic bone marrow transplantation.
    O'Reilly RJ
    Semin Hematol; 1992 Apr; 29(2 Suppl 1):20-6. PubMed ID: 1615341
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of monoclonal antibodies in graft versus host disease prevention.
    Brenner MK; Grob JP; Prentice HG
    Haematologia (Budap); 1986; 19(3):167-76. PubMed ID: 3536685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.